3D Signatures Announces Name Change to Telo Genomics Corp.
April 08, 2019 09:00 ET
|
3D Signatures Inc.
TORONTO, April 08, 2019 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V: DXD) (the “Company” or “3DS”) is pleased to announce that it has changed its corporate name to Telo Genomics Corp. effective...
3D Signatures Announces Intention to File for Bankruptcy
May 31, 2018 12:35 ET
|
3D Signatures Inc.
TORONTO, May 31, 2018 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), a personalized medicine company with a proprietary software platform...
3D Signatures Strengthens Its Intellectual Property With New Patents Issued for Tests in Alzheimer’s Disease, Hodgkin’s Lymphoma and Multiple Myeloma
May 10, 2018 09:00 ET
|
3D Signatures Inc.
TORONTO, May 10, 2018 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), a personalized medicine company with a proprietary software platform...
3D Signatures Inc. Announces Successful Scoring Model Development and Analytical Validation of the Telo-HL(TM) Test for Hodgkin’s Lymphoma
April 03, 2018 08:00 ET
|
3D Signatures Inc.
TORONTO, April 03, 2018 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), a personalized medicine company with a proprietary software platform...
3D Signatures Collaborates with MDxHealth to Evaluate Telo-PC™ Test in Prostate Cancer
March 28, 2018 08:00 ET
|
3D Signatures Inc.
TORONTO, March 28, 2018 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the “Company” or "3DS"), a personalized medicine company with a proprietary software platform...
3D Signatures Inc. and l’Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) Announce Collaboration to Combine TeloView™ with Genome Sequence Analysis in Lung Cancer
March 06, 2018 08:00 ET
|
3D Signatures Inc.
TORONTO, March 06, 2018 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), a personalized medicine company with a proprietary software platform...
3D Signatures Reports Quarter Ended December 31, 2017 Financial Results
March 01, 2018 17:00 ET
|
3D Signatures Inc.
TORONTO, March 01, 2018 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), a personalized medicine company with a proprietary software platform based...
3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HL™ Test for Hodgkin’s Lymphoma
February 20, 2018 08:00 ET
|
3D Signatures Inc.
TORONTO, Feb. 20, 2018 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS") is pleased to announce that a preliminary third-party analysis of the...
3D Signatures Inc. Announces Changes To Its Board of Directors
February 12, 2018 16:30 ET
|
3D Signatures Inc.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Feb. 12, 2018 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the...
3D Signatures Inc. Announces the Closing of its Non-Brokered Private Placement
December 05, 2017 18:53 ET
|
3D Signatures Inc.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 05, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the...